In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of telmisartan
- 707 Downloads
Telmisartan (TEL) is a BCS Class II drug having dissolution rate limited bioavailability. The aim of work was to enhance the solubility of TEL so that bioavailability problems are solved. β-Cyclodextrin (β-CD) based nanosponges (NSs) were formed by cross-linking β-CD with carbonate bonds, which were porous as well as nanosized. Drug was incorporated by solvent evaporation method. The effect of ternary component alkalizer (NaHCO3) on solubility of TEL was studied. In order to find out the solubilization efficiency of NS, phase solubility study was carried out. Saturation solubility and in vitro dissolution study of β-CD complex of TEL was compared with plain TEL and NS complexes of TEL. The NS and NS complexes of TEL were characterized by differential scanning calorimetry, powder X-ray diffraction, Fourier transform infrared spectroscopy, nuclear magnetic resonance and scanning electron microscope. It was found that solubility of TEL was increased by 8.53-fold in distilled water; 3.35-fold in 0.1 N HCl and 4.66-fold in phosphate buffer pH 6.8 by incorporating NaHCO3 in drug–NS complex than TEL. It was found that the NaHCO3 in NS based complex synergistically enhanced dissolution of TEL by modulating microenvironmental pH and by changing amorphization of the drug. The highest solubility and in vitro drug release was observed in inclusion complex prepared from NS and NaHCO3. An increase of 54.4 % in AUC was seen in case the ternary NS complex whereas β-CD ternary complex exhibited an increase of 79.65 %.
KeywordsNanosponge Telmisartan β-Cyclodextrin Sodium bicarbonate
Conflicts of interest
The author reports no conflicts of interest financial or otherwise.
- 8.Nakatani, M., Takeshi, S., Ohki, T., Toyoshima, K.: Solid TEL pharmaceutical formulations. US Patent 2004/0110813 A1, 2004Google Scholar
- 10.Trotta, F., Tumiatti, W.: Cyclodextrin-based NS as a vehicle for antitumoral drugs. World Patent Number WO/2009/003656, 2009Google Scholar
- 11.Higuchi, T., Connors, K.: Phase solubility techniques. In: Reilly, C. (ed.) Advances in Analytical Chemistry and Instrumentation, pp. 117–212. Wiley–Interscience, New York (1965)Google Scholar
- 13.Marques, M.: Dissolution media simulating fasted and fed state. Dissolution Technol. 11(2), 16 (2004)Google Scholar
- 14.Shimasaki, M., Yamashit, K.: Pharmacokinetics of 14C-TEL (2): plasma concentration and distribution of 14C-TEL after repeated oral administration to rats. Xenobiol. Metab. Dispos. 14, 432–436 (1999)Google Scholar
- 15.Brahmankar, D.M., Jaiswal, S.B.: Biopharmaceutics and Pharmacokinetics: A Treatise. Vallabh Prakashan, New Delhi (2005)Google Scholar
- 16.Chada, R., Kashid, N., Saini, A.: Account of analytical techniques employed for the determination of thermodynamics of inclusion complexation of drugs with cyclodextrins. J. Sci. Ind. Res. 63, 211–229 (2004)Google Scholar